Geode Capital Management, LLC Gritstone Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,246,527 shares of GRTS stock, worth $37,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,246,527

Previous 1,045,670 19.21%

Holding current value

$37,395

Previous $648,000 11.42%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.45 - $0.71 $90,385 - $142,608	200,857 Added 19.21%	1,246,527 $722,000
Q2 2024 Aug 09, 2024	SELL	$0.62 - $2.35 $584,115 - $2.21 Million	-942,122 Reduced 47.4%	1,045,670 $648,000
Q1 2024 May 13, 2024	BUY	$1.96 - $2.9 $160,757 - $237,855	82,019 Added 4.3%	1,987,792 $5.11 Million
Q4 2023 Feb 13, 2024	BUY	$1.28 - $2.85 $177,502 - $395,220	138,674 Added 7.85%	1,905,773 $3.89 Million
Q3 2023 Nov 13, 2023	BUY	$1.19 - $2.26 $108,338 - $205,752	91,041 Added 5.43%	1,767,099 $3.04 Million
Q2 2023 Aug 11, 2023	BUY	$1.66 - $3.03 $1.55 Million - $2.82 Million	931,478 Added 125.1%	1,676,058 $3.27 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.74 $69,463 - $121,968	32,612 Added 4.58%	744,580 $2.07 Million
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $232,446 - $419,902	107,118 Added 17.71%	711,968 $2.46 Million
Q3 2022 Nov 14, 2022	SELL	$2.46 - $4.75 $2,250 - $4,346	-915 Reduced 0.15%	604,850 $1.55 Million
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $456,279 - $1.12 Million	-257,785 Reduced 29.85%	605,765 $1.47 Million
Q1 2022 May 13, 2022	SELL	$4.03 - $12.19 $16,837 - $50,929	-4,178 Reduced 0.48%	863,550 $3.56 Million
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $1.4 Million - $2.19 Million	159,660 Added 22.55%	867,728 $11.2 Million
Q3 2021 Nov 12, 2021	BUY	$6.41 - $13.54 $1.12 Million - $2.36 Million	173,972 Added 32.57%	708,068 $7.65 Million
Q2 2021 Aug 13, 2021	BUY	$8.13 - $10.2 $771,244 - $967,612	94,864 Added 21.6%	534,096 $4.88 Million
Q1 2021 May 12, 2021	BUY	$4.07 - $27.11 $90,431 - $602,357	22,219 Added 5.33%	439,232 $4.14 Million
Q4 2020 Feb 12, 2021	BUY	$2.57 - $4.22 $29,017 - $47,648	11,291 Added 2.78%	417,013 $1.64 Million
Q3 2020 Nov 13, 2020	BUY	$2.63 - $8.09 $44,157 - $135,831	16,790 Added 4.32%	405,722 $1.08 Million
Q2 2020 Aug 13, 2020	BUY	$5.69 - $8.17 $337,735 - $484,938	59,356 Added 18.01%	388,932 $2.58 Million
Q1 2020 May 14, 2020	BUY	$5.47 - $11.3 $120,525 - $248,984	22,034 Added 7.16%	329,576 $1.92 Million
Q4 2019 Feb 13, 2020	BUY	$7.07 - $11.61 $140,502 - $230,725	19,873 Added 6.91%	307,542 $2.76 Million
Q3 2019 Nov 12, 2019	BUY	$8.45 - $12.28 $29,862 - $43,397	3,534 Added 1.24%	287,669 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $1.66 Million - $2.83 Million	180,189 Added 173.35%	284,135 $3.17 Million
Q1 2019 May 14, 2019	BUY	$9.97 - $18.96 $153,218 - $291,377	15,368 Added 17.35%	103,946 $1.38 Million
Q4 2018 Feb 13, 2019	BUY	$11.61 - $31.1 $1.03 Million - $2.75 Million	88,578 New	88,578 $1.37 Million

Others Institutions Holding GRTS

# of Institutions

Shares Held

36M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Gritstone Bio, Inc. Transaction History